ischaemic stroke. Transient cerebral ischaemic attacks and related syndromes ,Vascular syndromes of brain in cerebrovascular diseases
Conditions
Interventions
Intervention 1: control group: Lab tests for patients Adjusting the dose patients according to clinical protocols that have been developed based on the latest available protocols thrombotic therapy De
control group: Lab tests for patients Adjusting the dose patients according to clinical protocols that have been developed based on the latest available protocols thrombotic therapy Determine the ther
Intervention group: Lab tests for patients The necessary training related to using warfarin correctly To familiarize the patients with risk factors for recurrent stroke and bleeding and help in contro
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with ischemic stroke have been one reason; Patients whose disease is confirmed by a neurologist doctor and refer to warfarin clinics in Specified time range of in the study; Patients under 76 years are allowed to enter the study; Patients who live in shiraz or around the city of Shiraz and refer to clinic in the established days; Patients who are committed to the principles of the laboratory tests are required to use the unit for lab test checking; Patients willing to participate in the study and signed an informed consent form 7 Patients taking warfarin for one month before starting the study Exclusion criteria: Patients who have to be discontinued warfarin for any reason; Deaths during the study period due to complications from a stroke or other causes; Patients did not provide the necessary cooperation to control their INR during the study period
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| INR. Timepoint: Baseline and then at intervals required. Method of measurement: blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrent stroke and bleeding. Timepoint: At each visit of patients. Method of measurement: question and observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMrs. M. kargar (Executive)
Shiraz University of Medical Sciences
Outcome results
None listed